Internal Market (NHS)

Internal Market (NHS)
Name	Internal Market (NHS)
Introduced	1990
Primary authority	National Health Service
Jurisdiction	United Kingdom
Model	purchaser–provider split
Status	implemented / modified

Internal Market (NHS)

The Internal Market (NHS) was a major reform of the National Health Service in the United Kingdom that introduced a purchaser–provider split and market mechanisms into publicly funded healthcare delivery. Advocates tied the design to principles associated with Margaret Thatcher, Kenneth Clarke, John Major, and the Conservative Party (UK), while critics invoked precedents from Aneurin Bevan and linked debates to the National Health Service and Community Care Act 1990. The reform reshaped relationships among departmental government departments such as the Department of Health and Social Care, statutory bodies like NHS England, and institutional actors including primary care trusts, NHS trusts, and independent providers.

Background and Rationale

The Internal Market emerged amid late 20th‑century policy shifts influenced by proponents from Think tanks such as the Adam Smith Institute, Institute for Fiscal Studies, and Centre for Policy Studies, and policymakers including Nigel Lawson and Norman Fowler. Reformers cited experiences from United States, Netherlands, and Australia to justify competition between purchasers and providers, aiming to mirror systems in Medicare (United States), Health Maintenance Organization models, and the purchaser‑provider separation seen in New Zealand under Rogernomics. Opponents referenced the postwar settlement forged by Clement Attlee and invoked institutions like the British Medical Association and unions including the Royal College of Nursing to contest marketisation.

Structure and Mechanisms

The Internal Market established a formal split: commissioning bodies (initially family practitioner committees and later health authorities and primary care trusts) purchased services from provider organisations (initially NHS trusts, later foundation trusts and private independent sector hospitals). Payment systems included case‑mix mechanisms influenced by Diagnosis Related Group research from DRG pioneers and elements later codified in Payment by Results tariffs. Contracting relied on legal frameworks from the National Health Service and Community Care Act 1990 and oversight by regulators such as Monitor (NHS) and later Care Quality Commission. Policy instruments drew on procurement law, commissioning guidance associated with NHS Confederation advice, and performance metrics influenced by the Audit Commission and think tanks including the King's Fund.

Implementation and Evolution

Implementation proceeded in phases under Secretaries of State such as Kenneth Clarke, Virginia Bottomley, and Alan Milburn, with structural changes across administrations including New Labour reforms that introduced NHS Plan 2000 initiatives and later reorganisations under the Health and Social Care Act 2012. Pilots and demonstration projects involved entities like Oxford Radcliffe Hospitals NHS Trust and Royal Free London NHS Foundation Trust and interactions with private operators such as Circle Health Group and BMI Healthcare. Over time, market elements were modified by central commissioning via NHS England, the rise of clinical commissioning groups, and regulatory shifts under figures like David Nicholson and Simon Stevens.

Impact on Health Outcomes and Efficiency

Empirical analyses referenced reports by institutions including the National Audit Office, Organisation for Economic Co‑operation and Development, and academic centres at London School of Economics, University of Oxford, and Imperial College London. Studies compared indicators such as waiting times, hospital productivity, and mortality rates with international benchmarks like OECD Health Statistics and national data series from Office for National Statistics. Some evaluations credited market mechanisms with reducing elective waiting lists and stimulating managerial innovation in trusts like Birmingham Heartlands Hospital, while others found mixed effects on population health measures and cost‑effectiveness relative to systems in Sweden, Germany, and France.

Controversies and Criticisms

Critics including the Labour Party (UK), Amnesty International, and professional bodies such as the British Medical Association argued the Internal Market eroded universality and integrated care, citing cases like disputes over contractual closures at Whittington Hospital and concerns raised during inquiries into services at Mid Staffordshire NHS Foundation Trust. Debates touched on equity, transaction costs, and regulatory capture, with commentators from Public Accounts Committee and scholars like Anthony Giddens and Julian Le Grand contributing competing interpretations. Legal challenges invoked procurement jurisprudence from the European Court of Justice and domestic litigation in Royal Courts of Justice.

Comparative Perspectives and International Models

Comparative literature situated the Internal Market alongside systems such as the social insurance models of Germany (healthcare system), the purchaser‑provider split in New Zealand under Rogernomics, and mixed public–private arrangements in Netherlands (healthcare system). International organisations including the World Health Organization and European Commission produced policy briefs that informed cross‑national learning, while bilateral exchanges with United States Department of Health and Human Services and ministries in Sweden and Denmark influenced reforms. Debates continue over transplantation of market mechanisms, with comparative case studies from Spain (healthcare), Italy (healthcare system), and Canada (healthcare) shaping contemporary health policy discourse.

Category:National Health Service